Mixed Results For EMA's Early Pediatric Advice Pilot
This article was originally published in SRA
Executive Summary
The European Medicines Agency has accepted only four of the 15 applications received so far under its early interaction pilot, which offers free scientific advice to drug companies in an effort to stimulate pediatric development1,2.
You may also be interested in...
‘Not What We Expected,’ R&D Industry Says Of ‘Onerous’ EU Paediatric Regulation
The research-based drug industry has not minced its words in describing the problems it has faced from the EU Paediatric Regulation over the past 10 years.
Parallel EMA-FDA Pediatric Advice On The Cards For Companies
The European Medicines Agency is working on plans to supplement its early advice pilot on pediatric development by providing joint advice with the US FDA and, in some cases, by arranging for a three-way dialogue with companies.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.